Correlation Between Endocyte and ProShares UltraShort
Can any of the company-specific risk be diversified away by investing in both Endocyte and ProShares UltraShort at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Endocyte and ProShares UltraShort into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Endocyte and ProShares UltraShort Bloomberg, you can compare the effects of market volatilities on Endocyte and ProShares UltraShort and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Endocyte with a short position of ProShares UltraShort. Check out your portfolio center. Please also check ongoing floating volatility patterns of Endocyte and ProShares UltraShort.
Diversification Opportunities for Endocyte and ProShares UltraShort
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Endocyte and ProShares is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Endocyte and ProShares UltraShort Bloomberg in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProShares UltraShort and Endocyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Endocyte are associated (or correlated) with ProShares UltraShort. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProShares UltraShort has no effect on the direction of Endocyte i.e., Endocyte and ProShares UltraShort go up and down completely randomly.
Pair Corralation between Endocyte and ProShares UltraShort
If you would invest (100.00) in Endocyte on January 19, 2024 and sell it today you would earn a total of 100.00 from holding Endocyte or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Endocyte vs. ProShares UltraShort Bloomberg
Performance |
Timeline |
Endocyte |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ProShares UltraShort |
Endocyte and ProShares UltraShort Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Endocyte and ProShares UltraShort
The main advantage of trading using opposite Endocyte and ProShares UltraShort positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Endocyte position performs unexpectedly, ProShares UltraShort can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProShares UltraShort will offset losses from the drop in ProShares UltraShort's long position.Endocyte vs. Canada Goose Holdings | Endocyte vs. Boot Barn Holdings | Endocyte vs. Herc Holdings | Endocyte vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |